Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zszong@hotmail.com
    Member
    • Sep 2012
    • 17

    #1

    pacbio sequence error correction

    Hi all,

    I have some pacbio long read data, about 10x coverage of a 120M genome. I already have the reference genome. However it is not complete and there are many gaps in it. What I am trying to do is to error correct my pacbio sequence and assemble the genome. Later on I will add more illumina data trying to close the gaps.

    My question about he error correction is: Can I use the incomplete reference genome to error correct my pacbio data? My plan is to convert the genome fasta into pacBioToCA required frg format. And then feed my pacbio data and the genome frg data to the correction pipeline to output error corrected data. My concern is : will pacBioToCA accept relatively long genome scalfold data as high identity sequence to correct my pacbio data?

    Suggestions and help is greatly appreciatedl

    Stuart
  • zszong@hotmail.com
    Member
    • Sep 2012
    • 17

    #2
    I am not able to figure out how I can use the incomplete reference genome for error correction. It looks like FastaToCA converts fastq file to frg file so that it can be used as high identity sequence for error correction. However, the incomplete genome assembly in fasta file. there is no quality score files can be found. How can I get around this?

    many thanks!

    Stuart

    Comment

    • mchaisso
      Member
      • Apr 2008
      • 84

      #3
      Perhaps use the pbjelly pipeline to fill gaps? Also, with an appropriate pipeline (quiver: https://github.com/PacificBiosciences/GenomicConsensus) you may not need error correction to call accurate consensus.

      cheers,
      -mark

      Comment

      • zszong@hotmail.com
        Member
        • Sep 2012
        • 17

        #4
        Thanks for the tips! Mark. It looks like it will take me a while to figure this out. However, It sounds like interesting to me when you say I might not need to do error correction for pacbiodate since it it has 15% error rate.

        STuart

        Comment

        • jbingham
          Member
          • Jul 2011
          • 24

          #5
          Some more tips: if you want to use pacBioToCA, the approach would be to use the raw Illumina data as input to the correction step, not the draft assembly. The advantage of going back to the raw data is you may be able to correct assembly errors. The disadvantage is it takes longer to run.

          If you want to keep the assembly as is, you can install SMRT Analysis and use AHA (a hybrid assembler) to scaffold it, provided your the genome is less than about 200 MB. For larger genomes, or to really focus on the gap-filling, you can use pbjelly.

          Finally, the "no error correction" suggestion refers to the new algorithm HGAp: http://www.pacbiodevnet.com/hgap. You'll need more PacBio coverage to go that route. The benefit is you may be able to close more gaps and get a final result that's potentially as accurate as Sanger finishing.

          Comment

          • zszong@hotmail.com
            Member
            • Sep 2012
            • 17

            #6
            Thanks for your tips! jbingham. I am in the process of generating short illumina data for the error correction. I think I don't have enough coverage to try the new algorithm since my pacbio data only gives 3-4 times coverage when look into those data more carefully. The most majority of them are less than 500bp and 1000bp. Longest read is 13kb. I will post my process later.

            Thanks again to Winsettz and jbingham for helping out here!

            Stuart

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              07-31-2026, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 12:22 PM
            0 responses
            12 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-11-2026, 10:35 AM
            0 responses
            13 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-06-2026, 07:41 AM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-03-2026, 10:13 AM
            0 responses
            48 views
            0 reactions
            Last Post SEQadmin2  
            Working...